MHR Fund Management Amends Titan International Stake

TL;DR

MHR Fund Management updated their Titan International (TWI) filing, watch for share changes.

AI Summary

On May 14, 2024, MHR Fund Management LLC, along with affiliated entities and individuals including Mark H. Rachesky, M.D., filed an amendment to their Schedule 13D. This filing indicates a change in their beneficial ownership of Titan International Inc. (TWI). The specific details of the change in ownership percentage or the exact number of shares acquired or disposed of are not provided in this excerpt.

Why It Matters

This filing signals a potential shift in the major shareholder landscape of Titan International Inc., which could influence the company's strategic direction or future corporate actions.

Risk Assessment

Risk Level: medium — Schedule 13D filings often precede significant corporate events or changes in control, introducing uncertainty.

Key Players & Entities

• MHR Fund Management LLC (company) — Filer of the Schedule 13D/A
• Mark H. Rachesky, M.D. (person) — Member of the reporting group
• Titan International Inc. (company) — Subject company
• MHR HOLDINGS LLC (company) — Member of the reporting group
• MHR INSTITUTIONAL ADVISORS III LLC (company) — Member of the reporting group
• MHR INSTITUTIONAL PARTNERS III LP (company) — Member of the reporting group

FAQ

Filing Documents

• d823077dsc13da.htm (SC 13D/A) — 106KB
• 0001193125-24-138379.txt ( ) — 108KB

Signatures

Signatures 11 Table of Contents Page 8 of 11 Pages This statement on Schedule 13D (this Statement ) amends and supplements, as Amendment No. 10, the Schedule 13D filed on January 21, 2014 (the Initial Schedule 13D ), which was amended on February 20, 2014 by Amendment No. 1 to the Initial Schedule 13D ( Amendment No. 1 ), on February 27, 2014 by Amendment No. 2 to the Initial Schedule 13D ( Amendment No. 2 ), on April 24, 2014 by Amendment No. 3 to the Initial Schedule 13D ( Amendment No. 3 ), on April 30, 2014 by Amendment No. 4 to the Initial Schedule 13D ( Amendment No. 4 ), on July 31, 2014 by Amendment No. 5 to the initial Schedule 13D ( Amendment No. 5 ), on December 10, 2014 by Amendment No. 6 to the initial Schedule 13D ( Amendment No. 6 ), on February 29, 2016 by Amendment No. 7 to the Initial Schedule 13D ( Amendment No. 7 ), on October 4, 2016 by Amendment No. 8 to the Initial Schedule 13D ( Amendment No. 8 ), and on February 26, 2019 by Amendment No. 9 to the Initial Schedule 13D ( Amendment No. 9 and, together with the Initial Schedule 13D and Amendment No. 1 through Amendment No. 8, the Schedule 13D ), and relates to shares of common stock, no par value per share (the Common Stock ), of Titan International, Inc. (the Issuer ). Capitalized terms used in this Statement but not defined herein shall have the respective meanings given to such terms in Amendment No. 9.

Purpose of Transaction

Item 4. Purpose of Transaction.

is hereby amended to add the following

Item 4 is hereby amended to add the following: All of the Common Stock reported on this Statement were acquired for investment purposes. The Reporting Persons intend to review their holdings in the Issuer on a continuing basis and as part of this ongoing review evaluate various alternatives that are or may become available with respect to the Issuer and its securities. Except as otherwise set forth in this Statement, neither the Reporting Persons nor, to the best of their knowledge, any of the other persons identified in response to Item 2 hereof, has any plans or proposals that relate to or would result in the occurrence of any of the transactions described in subparagraphs (b) through (j) of Item 4 of Schedule 13D. (a) The Reporting Persons may from time to time and at any time (in accordance with any trading policy of the Issuer or its subsidiaries and affiliates that may then be applicable to the Reporting Persons) in their sole discretion acquire, or cause to be acquired, additional equity or debt securities or other instruments of the Issuer, its subsidiaries or affiliates, or dispose, or cause to be disposed, such equity or debt securities or instruments, in any amount that the Reporting Persons may determine in their sole discretion, through public or private transactions or otherwise. In addition to the foregoing, certain of the Reporting Persons are pursuing various alternatives with respect to the Issuers securities in order to create liquidity opportunities for limited partners of certain of such Reporting Persons. Among the alternatives being pursued, such Reporting Persons are considering forming a continuation vehicle or other special purpose vehicle that would continue to be controlled by certain of the Reporting Persons that would enable existing limited partners to continue their indirect investment in the Issuer, making an in-kind distribution to certain limited partners of certain of such Reporting Persons, or effecting a public or private tr

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this Statement is true, complete and correct. Date: May 14, 2024 MHR INSTITUTIONAL PARTNERS III LP By: MHR Institutional Advisors III LLC, its General Partner By: /s/ Janet Yeung Name: Janet Yeung Title: Authorized Signatory MHR INSTITUTIONAL ADVISORS III LLC By: /s/ Janet Yeung Name: Janet Yeung Title: Authorized Signatory MHR FUND MANAGEMENT LLC By: /s/ Janet Yeung Name: Janet Yeung Title: Authorized Signatory MHR HOLDINGS LLC By: /s/ Janet Yeung Name: Janet Yeung Title: Authorized Signatory MARK H. RACHESKY, M.D. By: /s/ Janet Yeung, Attorney in Fact

View Full Filing

View this SC 13D/A filing on SEC EDGAR